We also demonstrated that LAPTM4B promoted survival and autophagy as well as activated the NRF2 stress response pathway in lung cancer cells, particularly those with mutations in the KRAS oncogene, under serum deprived conditions. This evidence concerns the gene LAPTM4B and lung carcinoma.